HISTIOCYTIC SARCOMA

HISTIOCYTIC SARCOMA was reported 78 times

HISTIOCYTIC SARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 4 0.0004
1 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
2 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
3 Topoisomerase Inhibitor [EPC] 16 0.0002
4 Alkylating Drug [EPC] 24 0.0001
5 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
6 Asparagine-specific Enzyme [EPC] 1 0.0001
7 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
8 Purine Antimetabolite [EPC] 5 0.0001
9 CD20-directed Cytolytic Antibody [EPC] 11 0.0000
10 BCL-2 Inhibitor [EPC] 2 0.0000
11 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
12 Platinum-based Drug [EPC] 8 0.0000
13 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
15 Muscle Relaxant [EPC] 1 0.0000
16 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
17 Kinase Inhibitor [EPC] 11 0.0000
18 Corticosteroid [EPC] 25 0.0000
19 Interleukin-12 Antagonist [EPC] 2 0.0000
20 Interleukin-23 Antagonist [EPC] 2 0.0000
21 Proteasome Inhibitor [EPC] 2 0.0000
22 Thalidomide Analog [EPC] 6 0.0000
23 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
24 Leukocyte Growth Factor [EPC] 1 0.0000
25 Aldosterone Antagonist [EPC] 1 0.0000
26 Janus Kinase Inhibitor [EPC] 1 0.0000
27 Microtubule Inhibitor [EPC] 1 0.0000
28 Opioid Agonist [EPC] 1 0.0000
29 Factor Xa Inhibitor [EPC] 1 0.0000
30 Osmotic Laxative [EPC] 1 0.0000
31 Vitamin D [EPC] 1 0.0000
32 Vitamin B12 [EPC] 1 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Loop Diuretic [EPC] 1 0.0000
35 Benzodiazepine [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000